Apratim Jash

PhD; Cornell University || Scientist; Alexion, AstraZeneca Rare Disease

Role
Scientist Ii, Injectable Drug Product Development at Alexion Pharmaceuticals, Inc.
Location
New Haven, CT, US
LinkedIn followers
500 followers

About Apratim Jash

As a Scientist at Alexion, AstraZeneca Rare Disease Unit, a global leader in rare disease innovation, I work on injectable drug product development, applying my expertise in liposome-based drug delivery systems. I have a PhD from Cornell University, where I conducted research on synthesizing non-immunogenic lipid nanoparticles for organ-targeted oral delivery of bioactives, resulting in multiple publications in prestigious journals and awards.

Experience

  1. Scientist Ii, Injectable Drug Product Development

    Alexion Pharmaceuticals, Inc.

    Nov 2024 — Present · New Haven, CT, US

Education

  • University of Guelph

    Master of Science (M.Sc.), Biomaterials

  • Cornell University

    Doctor of Philosophy - PhD

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Apratim Jash — Scientist Ii, Injectable Drug Product Development at Alexion Pharmaceuticals, Inc. in New Haven, CT, US | Unifers